This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
Save the date for next year!
March 18–20, 2024 | Barcelona, Spain

Michelle Chen
Chief Business Officer at Insilico Medicine


Michelle Chen is the Chief Business Officer of Insilico Medicine, a leader in the AI-powered drug discovery and development company.

She is responsible for company’s strategies, business and corporate development, revenue growth and US operations. As a biotech executive, Michelle brings in 20+ years of experience in biopharma and technology industries, and worked at multi-national companies such as Roche, Merck, BioMarin, Agilent, as well as small biotech companies with a strong track record of success in BD&L, M&A, R&D, marketing, and product commercialization.

Michelle has a Ph.D. in Biochemistry from the University of Washington, did her postdoctoral work at UCSF, and received the Bioinformatics training at Stanford.

Agenda Sessions

  • What's next in...oncology?

  • APAC partnering: where are we and where does the future lie?


Speakers at this event